Sign inJoin waitlistJoin the waitlist

Matthew Ciorba

Program Director, T32 Training in Academic Gastroenterology · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

T32 Training in Academic Gastroenterology · Washington University/B-JH/SLCH Consortium
Present
Inflammatory Bowel Diseases Center · Washington University/B-JH/SLCH Consortium
Present
IBD Research · Washington University/B-JH/SLCH Consortium
Present

Gastroenterology
Washington University School of Medicine
2004–2007
Internal Medicine
Barnes-Jewish Hospital
2001–2003
University of Iowa Roy J. and Lucille A. Carver College of Medicine
1997–2001

Research

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Science Immunology · 2020 · 813 citations
Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays
Gut · 2015 · 434 citations
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study
Annals of Internal Medicine · 2021 · 275 citations

Parakkal Deepak
33 papers
William Stenson
11 papers
Martin Gregory
10 papers · 9 as a resident
Nicholas Davidson
10 papers
Quazim Alayo
8 papers · 8 as a resident
Rodney Newberry
8 papers
AG
Alexandra Gutierrez
7 papers
GC
George Christophi
7 papers · 2 as a fellow
Andres Yarur
6 papers
Edward Loftus
6 papers
Ta-Chiang Liu
6 papers
Anas Gremida
5 papers · 4 as a fellow

Grants

Host-Environment Interactions in the Pathophysiology of Digestive Disease
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $320.9K · Washington University
2000–2030
Clinical/Laboratory Training Academic Gastroenterology
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $822.3K · Washington University
1975–2030
Targeting Tryptophan Metabolism in Rectal Cancer
National Cancer Institute · R01
Contact PI · $2.1M · Washington University
2023–2029
Mechanisms of Gastrointestinal COVID-19
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.1M · Washington University
2022–2027

Clinical trials

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
2014–2021
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Sub-investigator · Recruiting · Phase 1
Washington University School of Medicine
2023–2029
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Sub-investigator · Recruiting · Phase 1, Phase 2
Washington University School of Medicine
2020–2030